Regulatory delay and the timing of product innovation

被引:13
|
作者
Prieger, James E. [1 ]
机构
[1] Univ Calif Davis, Dept Econ, Davis, CA 95616 USA
关键词
D O I
10.1016/j.ijindorg.2006.05.001
中图分类号
F [经济];
学科分类号
02 ;
摘要
This paper examines how regulatory delay affects innovation by a regulated firm. When product introduction costs fall over time, an extra day of regulatory delay increases time to introduction by more than a day. When the uncertainty of regulatory delay increases, a risk neutral firm responds by moving up the product introduction. The model places testable restrictions on the empirical relationship between introduction delay and regulatory delay, and is consistent with data gathered from a large U.S. telecommunications provider. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:219 / 236
页数:18
相关论文
共 50 条
  • [21] I Don't "Recall": The Decision to Delay Innovation Launch to Avoid Costly Product Failure
    Kim, Byungyeon
    Koenigsberg, Oded
    Ofek, Elie
    MANAGEMENT SCIENCE, 2022, 68 (12) : 8889 - 8908
  • [22] Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem-Are We Ready for a Revolution?
    Macdonald, Judith C.
    Isom, David C.
    Evans, Daniel D.
    Page, Katy J.
    FRONTIERS IN MEDICINE, 2021, 8
  • [23] AIRBAGS AND REGULATORY DELAY
    FELIX, MO
    ISSUES IN SCIENCE AND TECHNOLOGY, 1985, 1 (02) : 7 - 7
  • [24] Product Innovation, Process Innovation, and Size
    Michael Fritsch
    Monika Meschede
    Review of Industrial Organization, 2001, 19 : 335 - 350
  • [25] Regulatory and Reimbursement Innovation
    Lindor, Rachel A.
    Allocco, Scott J.
    Cheatham, Lee
    Cortese, Denis A.
    Hall, Ralph F.
    Mangold, William J., Jr.
    Pizziconi, Vincent
    Poste, George
    Quinn, Bruce
    Roth, Mollie
    Saks, Michael J.
    Wassman, E. Robert
    Woosley, Raymond L.
    Marchant, Gary E.
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (176)
  • [26] Innovation in Clinical Trial Design and Product Promotion: Evolving the Patient Perspective With Regulatory and Technological Advances
    Mary L. Raber-Johnson
    Wolfgang E. Gallwitz
    Eugene J. Sullivan
    Philip Storer
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 519 - 527
  • [27] PRODUCT MEANING IN DIGITAL PRODUCT INNOVATION
    Wang, Gongtai
    Henfridsson, Ola
    Nandhakumar, Joe
    Yoo, Youngjin
    MIS QUARTERLY, 2022, 46 (02) : 947 - 976
  • [28] Innovation in Clinical Trial Design and Product Promotion: Evolving the Patient Perspective With Regulatory and Technological Advances
    Raber-Johnson, Mary L.
    Gallwitz, Wolfgang E.
    Sullivan, Eugene J.
    Storer, Philip
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (03) : 519 - 527
  • [29] Regulatory Requirements and Innovation: A Comparison of the Dermatologic Antifungal Drug Product Markets in Brazil and United States
    Kollross, Bianca
    Cunha-Filho, Marcilio
    Gelfuso, Guilherme Martins
    Gratieri, Tais
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (05) : 661 - 668
  • [30] Market Innovation and Product Excellence in Indonesia: The Moderating Role of Product Innovation
    Wulandari, Siti Sri
    Widjaja, Sri Umi Mintarti
    Wahyono, Hari
    Utomo, Sugeng Hadi
    QUALITY-ACCESS TO SUCCESS, 2021, 22 (180): : 27 - 31